MedTrace Logo

Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia

NCT04326725 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-07-28

No results posted yet for this study

Summary

Healthcare professionals mainly doctors, nurses and their first degree relatives (spouse, father, mother, sister, brother, child) who have been started hydroxychloroquine(plaquenil) 200mg single dose repeated every three weeks plus vitaminC including zinc once a day were included in the study. Study has conducted on 20th of march. Main purpose of the study was to cover participants those who are facing or treating COVID19 infected patients in Ankara.

Conditions

Interventions

DRUG

Plaquenil 200Mg Tablet

health workers under risk who took this medications

Sponsors & Collaborators

  • Istinye University

    lead OTHER

Principal Investigators

  • Mahir M Ozmen, Professor · Istinye University

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-20
Primary Completion
2020-07-01
Completion
2020-09-01
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04326725 on ClinicalTrials.gov